Sort   by:  
 Page size 
UnknownResponding to and managing multijurisdictional outbreaks of COVID-19 in Canadian industrial worksite/work camp settings.
Not available
S-EPMC11133241 | biostudies-literature
UnknownThe Phosphate Binder Ferric Citrate and Mineral Metabolism and Inflammatory Markers in Maintenance Dialysis Patients: Results From Prespecified Analyses of a Randomized Clinical Trial.
Not available
S-EPMC4868355 | biostudies-literature
UnknownFerric citrate controls phosphorus and delivers iron in patients on dialysis.
Not available
S-EPMC4310662 | biostudies-literature
UnknownFrailty, Multimorbidity, and Polypharmacy: Exploratory Analyses of the Effects of Empagliflozin from the EMPA-KIDNEY Trial.
Not available
S-EPMC11390031 | biostudies-literature
UnknownEffects of empagliflozin on quality of life and healthcare use and costs in chronic kidney disease: a health economic analysis of the EMPA-KIDNEY trial.
Not available
S-EPMC12274867 | biostudies-literature
UnknownEffects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial.
Not available
S-EPMC7615591 | biostudies-literature
UnknownImpact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial.
Not available
S-EPMC7618536 | biostudies-literature
UnknownEmpagliflozin in Patients with Chronic Kidney Disease.
Not available
S-EPMC7614055 | biostudies-literature
UnknownLong-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease.
Not available
S-EPMC7616743 | biostudies-literature
UnknownThe Association of Statin Use with Cataract Progression and Cataract Surgery: The AREDS2 Report Number 8.
Not available
S-EPMC4808327 | biostudies-literature
Sort   by:  
 Page size